(RTTNews) - Johnson & Johnson (JNJ) Wednesday said it has initiated the submission of new drug application or NDA to Food and Drug Administration (FDA) for TAR-200 to treat patients with Bacillus ...
BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster than those assessed with TURBT alone ...
The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...
Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
A cancer-causing chemical is spewing into the air, in Niagara Falls, from the nearby Goodyear plant. That chemical is being ...
Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...
The Independent on MSN2d
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patientsThe study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study ...
A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder ...
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback